Literature DB >> 11481130

Comparison of desipramine and cognitive/behavioral therapy in the treatment of elderly outpatients with mild-to-moderate depression.

L W Thompson1, D W Coon, D Gallagher-Thompson, B R Sommer, D Koin.   

Abstract

The authors evaluated the efficacy of desipramine-alone, vs. cognitive/behavioral therapy-alone (CBT) vs. a combination of the two, for the treatment of depression in older adult outpatients. Patients (N=102) meeting criteria for major depressive disorder were randomly assigned to one of these three treatments for 16 to 20 therapy sessions. All treatments resulted in substantial improvement. In general, the CBT-Alone and Combined groups had similar levels of improvement. In most analyses, the Combined group showed greater improvement than the Desipramine-Alone group, whereas the CBT-Alone group showed only marginally better improvement. The combined therapies were most effective in patients who were more severely depressed, particularly when desipramine was at or above recommended stable dosage levels. The results indicate that psychotherapy can be an effective treatment for older adult outpatients with moderate levels of depression.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11481130

Source DB:  PubMed          Journal:  Am J Geriatr Psychiatry        ISSN: 1064-7481            Impact factor:   4.105


  18 in total

1.  The ACTIVE cognitive training interventions and the onset of and recovery from suspected clinical depression.

Authors:  Fredric D Wolinsky; Henry W Mahncke; Mark W Vander Weg; Rene Martin; Frederick W Unverzagt; Karlene K Ball; Richard N Jones; Sharon L Tennstedt
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  2009-07-17       Impact factor: 4.077

2.  Depression Treatment Among Rural Older Adults: Preferences and Factors Influencing Future Service Use.

Authors:  Katherine A Kitchen; Christine L McKibbin; Thomas L Wykes; Aaron A Lee; Catherine P Carrico; Katelynn A McConnell
Journal:  Clin Gerontol       Date:  2013       Impact factor: 2.619

3.  A network meta-analysis of the effects of psychotherapies, pharmacotherapies and their combination in the treatment of adult depression.

Authors:  Pim Cuijpers; Hisashi Noma; Eirini Karyotaki; Christiaan H Vinkers; Andrea Cipriani; Toshi A Furukawa
Journal:  World Psychiatry       Date:  2020-02       Impact factor: 49.548

Review 4.  Depression care for the elderly: reducing barriers to evidence-based practice.

Authors:  Kathleen Ell
Journal:  Home Health Care Serv Q       Date:  2006

Review 5.  A review of empirically supported psychological therapies for mood disorders in adults.

Authors:  Steven D Hollon; Kathryn Ponniah
Journal:  Depress Anxiety       Date:  2010-10       Impact factor: 6.505

Review 6.  Psychosocial interventions for late-life major depression: evidence-based treatments, predictors of treatment outcomes, and moderators of treatment effects.

Authors:  Dimitris N Kiosses; Andrew C Leon; Patricia A Areán
Journal:  Psychiatr Clin North Am       Date:  2011-06

Review 7.  Current status of psychotherapy for mental disorders in the elderly.

Authors:  Amber Gum; Patricia A Areán
Journal:  Curr Psychiatry Rep       Date:  2004-02       Impact factor: 5.285

Review 8.  Depression in adults: psychological treatments and care pathways.

Authors:  Jonathan Price; Rob Butler; Simon Hatcher; Michael Von Korff
Journal:  BMJ Clin Evid       Date:  2007-08-15

9.  Adding psychotherapy to antidepressant medication in depression and anxiety disorders: a meta-analysis.

Authors:  Pim Cuijpers; Marit Sijbrandij; Sander L Koole; Gerhard Andersson; Aartjan T Beekman; Charles F Reynolds
Journal:  World Psychiatry       Date:  2014-02       Impact factor: 49.548

10.  The efficacy of psychotherapy and pharmacotherapy in treating depressive and anxiety disorders: a meta-analysis of direct comparisons.

Authors:  Pim Cuijpers; Marit Sijbrandij; Sander L Koole; Gerhard Andersson; Aartjan T Beekman; Charles F Reynolds
Journal:  World Psychiatry       Date:  2013-06       Impact factor: 49.548

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.